About
Technology
Issues
FAQ
Links
Official Page
Expanding Indications for the Use of Class III Agents in Patients at High Risk for Sudden Death
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.